Samples from those who had COVID-19 could illuminate true infection rate, lethality, and vaccines
VirScan, a new antibody detection tool, can analyze blood samples collected from people who have recovered from COVID-19 to learn about how the virus affects the immune system and the epidemiology of the infection.
Combining brain imaging data with machine learning, researchers make new discoveries about how the brain controls the hand. The findings could lead to the development of more advanced neuroprosthetics. from Neuroscience News https://ift.tt/3tv7BbC
Comments
Post a Comment